CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE was reported 28 times

CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ULNAR NEURITIS 1 0.0189
1 FAT REDISTRIBUTION 1 0.0043
2 MASTOIDITIS 1 0.0010
3 DACTYLITIS 1 0.0010
4 INFUSION SITE BRUISING 2 0.0009
5 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
6 INFUSION SITE HAEMORRHAGE 2 0.0006
7 INFUSION SITE DISCHARGE 1 0.0006
8 STREPTOCOCCAL INFECTION 3 0.0005
9 AUTOIMMUNE THYROIDITIS 2 0.0005
10 JAW FRACTURE 1 0.0005
11 ENDODONTIC PROCEDURE 1 0.0004
12 RADICULOPATHY 1 0.0004
13 PHARYNGITIS 4 0.0003
14 FACIAL BONES FRACTURE 1 0.0003
15 MULTIPLE ALLERGIES 2 0.0003
16 HEPATIC PAIN 1 0.0002
17 HORDEOLUM 1 0.0002
18 GASTROENTERITIS VIRAL 4 0.0002
19 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
20 BEHAVIOUR DISORDER 1 0.0002
21 SKIN ATROPHY 1 0.0002
22 CONCUSSION 1 0.0001
23 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
24 BREAST CANCER FEMALE 3 0.0001
25 SPUTUM DISCOLOURED 1 0.0001
26 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
27 THERAPY CHANGE 1 0.0001
28 KNEE OPERATION 1 0.0001
29 SECRETION DISCHARGE 1 0.0001
30 IMMUNE SYSTEM DISORDER 1 0.0001
31 ANKYLOSING SPONDYLITIS 1 0.0001
32 RENAL INJURY 2 0.0001
33 MUSCULOSKELETAL CHEST PAIN 1 0.0001
34 PRODUCT USE COMPLAINT 1 0.0001
35 SCIATICA 1 0.0001
36 SINUSITIS 6 0.0001
37 GOUT 1 0.0001
38 END STAGE RENAL DISEASE 1 0.0001
39 INFLUENZA 5 0.0000
40 SNEEZING 1 0.0000
41 NEPHROLITHIASIS 2 0.0000
42 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
43 RENAL DISORDER 2 0.0000
44 BRONCHITIS 3 0.0000
45 ANHEDONIA 1 0.0000
46 OROPHARYNGEAL PAIN 3 0.0000
47 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
48 C-REACTIVE PROTEIN INCREASED 1 0.0000
49 DYSURIA 1 0.0000
50 DYSARTHRIA 1 0.0000
51 BLOOD PRESSURE INCREASED 4 0.0000
52 EXTRA DOSE ADMINISTERED 1 0.0000
53 PSORIATIC ARTHROPATHY 1 0.0000
54 RENAL IMPAIRMENT 2 0.0000
55 OSTEOARTHRITIS 1 0.0000
56 COVID-19 4 0.0000
57 RENAL FAILURE 3 0.0000
58 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
59 ARRHYTHMIA 1 0.0000
60 PRODUCTIVE COUGH 1 0.0000
61 LUNG DISORDER 1 0.0000
62 RHEUMATOID ARTHRITIS 2 0.0000
63 NASAL CONGESTION 1 0.0000
64 RHINORRHOEA 1 0.0000
65 INFUSION RELATED REACTION 1 0.0000
66 MOBILITY DECREASED 1 0.0000
67 HALLUCINATION 1 0.0000
68 CHRONIC KIDNEY DISEASE 1 0.0000
69 INJECTION SITE BRUISING 1 0.0000
70 INJECTION SITE HAEMORRHAGE 1 0.0000
71 PROSTATE CANCER 1 0.0000
72 BALANCE DISORDER 1 0.0000
73 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
74 MUSCULOSKELETAL STIFFNESS 1 0.0000
75 INSOMNIA 3 0.0000
76 GASTROINTESTINAL DISORDER 1 0.0000
77 SUICIDAL IDEATION 1 0.0000
78 BREAST CANCER 1 0.0000
79 SWELLING 1 0.0000
80 ANXIETY 3 0.0000
81 MIGRAINE 1 0.0000
82 DRUG INTOLERANCE 1 0.0000
83 FLUSHING 1 0.0000
84 ILLNESS 1 0.0000
85 ASTHMA 1 0.0000
86 CHILLS 1 0.0000
87 FEELING ABNORMAL 2 0.0000
88 EMOTIONAL DISTRESS 1 0.0000
89 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
90 LOSS OF CONSCIOUSNESS 1 0.0000
91 PSORIASIS 1 0.0000
92 DRY SKIN 1 0.0000
93 COUGH 2 0.0000
94 PRODUCT DOSE OMISSION ISSUE 2 0.0000
95 PAIN IN EXTREMITY 2 0.0000
96 HYPOAESTHESIA 1 0.0000
97 ACUTE KIDNEY INJURY 1 0.0000
98 PERIPHERAL SWELLING 1 0.0000
99 PARAESTHESIA 1 0.0000
100 ABDOMINAL DISCOMFORT 1 0.0000
101 TOXICITY TO VARIOUS AGENTS 1 0.0000
102 MYALGIA 1 0.0000
103 NASOPHARYNGITIS 1 0.0000
104 NAUSEA 4 0.0000
105 HEADACHE 3 0.0000
106 HYPERTENSION 1 0.0000
107 RASH 2 0.0000
108 DEPRESSION 1 0.0000
109 DECREASED APPETITE 1 0.0000
110 PAIN 2 0.0000
111 FALL 1 0.0000
112 ASTHENIA 1 0.0000
113 PRURITUS 1 0.0000
114 FATIGUE 2 0.0000
115 MALAISE 1 0.0000
116 VOMITING 1 0.0000
117 DIZZINESS 1 0.0000
118 DYSPNOEA 1 0.0000
119 DIARRHOEA 1 0.0000